Avalanche ($AVAX) eyeing $12-15 by late March 2026. Neutral RSI at 40.45; analysts target $12-15 range within 4-6 weeks. Current price $9.17 faces key resistance at $9.60. 🟢
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Avalanche ($AVAX) eyeing $12-15 by late March 2026. Neutral RSI at 40.45; analysts target $12-15 range within 4-6 weeks. Current price $9.17 faces key resistance at $9.60. 🟢